Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles

Sofia Ramiro; R. my L. M. Mostard; Robert B. M. Landewé

doi:10.1136/annrheumdis-2021-220077

Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles

Sofia Ramiro^*
, R. my L. M. Mostard
, Robert B. M. Landewé

^*Corresponding author for this work

Affiliatie UvA

Leiden University Medical Center
Department of Internal Medicine, Heerlen, Netherlands
Amsterdam Universitair Medische Centra, Radiotherapy, Amsterdam, Netherlands

Research output: Contribution to journal › Comment/Letter to the editor › Academic

26 Downloads (Pure)

Original language	English
Article number	e109
Pages (from-to)	E112
Journal	Annals of the rheumatic diseases
Volume	82
Issue number	5
Early online date	2021
DOIs	https://doi.org/10.1136/annrheumdis-2021-220077 https://doi.org/10.1136/annrheumdis-2021-220077
Publication status	Published - 1 May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Covid-19
epidemiology
health care
outcome assessment
COVID-19

Access to Document

Response-to.pdfFinal published version, 201 KBLicence: CC BY

Cite this

Ramiro, S., Mostard, R. M. L. M., & Landewé, R. B. M. (2023). Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles. Annals of the rheumatic diseases, 82(5), E112. Article e109. https://doi.org/10.1136/annrheumdis-2021-220077, https://doi.org/10.1136/annrheumdis-2021-220077

Ramiro, Sofia ; Mostard, R. my L. M. ; Landewé, Robert B. M. / Response to : 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles. In: Annals of the rheumatic diseases. 2023 ; Vol. 82, No. 5. pp. E112.

@article{94d96f41696d43ff8010809cf1912c2e,

title = "Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles",

keywords = "Covid-19, epidemiology, health care, outcome assessment, COVID-19",

author = "Sofia Ramiro and Mostard, \{R. my L. M.\} and Landew{\'e}, \{Robert B. M.\}",

year = "2023",

month = may,

day = "1",

doi = "10.1136/annrheumdis-2021-220077",

language = "English",

volume = "82",

pages = "E112",

journal = "Annals of the rheumatic diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "5",

}

Ramiro, S, Mostard, RMLM & Landewé, RBM 2023, 'Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles', Annals of the rheumatic diseases, vol. 82, no. 5, e109, pp. E112. https://doi.org/10.1136/annrheumdis-2021-220077, https://doi.org/10.1136/annrheumdis-2021-220077

Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles. / Ramiro, Sofia; Mostard, R. my L. M.; Landewé, Robert B. M.
In: Annals of the rheumatic diseases, Vol. 82, No. 5, e109, 01.05.2023, p. E112.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Response to

T2 - 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles

AU - Ramiro, Sofia

AU - Mostard, R. my L. M.

AU - Landewé, Robert B. M.

PY - 2023/5/1

Y1 - 2023/5/1

KW - Covid-19

KW - epidemiology

KW - health care

KW - outcome assessment

KW - COVID-19

UR - https://www.scopus.com/pages/publications/85100870220

U2 - 10.1136/annrheumdis-2021-220077

DO - 10.1136/annrheumdis-2021-220077

M3 - Comment/Letter to the editor

C2 - 33593737

SN - 0003-4967

VL - 82

SP - E112

JO - Annals of the rheumatic diseases

JF - Annals of the rheumatic diseases

IS - 5

M1 - e109

ER -

Ramiro S, Mostard RMLM, Landewé RBM. Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles. Annals of the rheumatic diseases. 2023 May 1;82(5):E112. e109. Epub 2021. doi: 10.1136/annrheumdis-2021-220077, 10.1136/annrheumdis-2021-220077

Response to: 'Correspondence on Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study'' by Charles

UN SDGs

Keywords

Access to Document

Other files and links

Cite this